Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation
Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Nov 3, 1999
Trial Information
Current as of March 21, 2025
Completed
Keywords
ClinConnect Summary
Low back pain is considered one of the most widely experienced health problems in the United States and the world. This condition is the second most frequent condition, after the common cold, for which people see a physician or lose days from work. Estimated costs to those who are severely disabled from low back pain range from $30-70 billion annually. Rates of spinal surgery in the U.S. have increased sharply over time, and researchers have documented 15-fold geographic variation in rates of these surgeries. In many cases, where one lives and who one sees for the problem appear to determin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Duration of symptoms: 6 or more weeks.
- • Treatments tried: Non-steroidal anti-inflammatory medical therapy and physical therapy.
- • Surgical screening: Persistent radicular pain provoked by moderate exercise, sitting, increased abdominal pressure, decreased mobility, list (scoliosis), straight leg raising.
- • Tests: MRI to confirm diagnosis and level(s).
- Exclusion Criteria:
- • Previous lumbar spine surgery.
- • Not a surgical candidate for any of these reasons: Overall health which makes spinal surgery too life-threatening to be an appropriate alternative, dramatic improvement with conservative care, or inability (for any reason) to undergo surgery within 6 months.
- • Possible pregnancy.
- • Active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer) is ineligible unless he or she has been treated with a curative intent AND there has been no clinical signs or symptoms of the malignancy for at least 5 years.
- • Current fracture, infection, and/or deformity (greater than 15 degrees of lumbar scoliosis, using Cobb measure technique) of the spine.
- • Age less than 18 years.
- • Cauda Equina syndrome or progressive neurological deficit (usually requiring urgent surgery).
- • Unavailability for follow-up (planning to move, no telephone, etc.) or inability to complete data surveys.
- • Symptoms less than 6 weeks.
- • Patient currently enrolled in any experimental "spine related" study.
Trial Officials
James N. Weinstein, DO, MS
Principal Investigator
Dartmouth-Hitchcock Medical Center
About Dartmouth Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. Louis, Missouri, United States
San Francisco, California, United States
Oakland, California, United States
Chicago, Illinois, United States
Scarborough, Maine, United States
Royal Oak, Michigan, United States
Omaha, Nebraska, United States
Lebanon, New Hampshire, United States
New York, New York, United States
New York, New York, United States
Cleveland, Ohio, United States
Decatur, Georgia, United States
Philadelphia, Pennsylvania, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials